Immunotherapy in Kidney Cancer
0 vistas
• 06/26/23
0
0
Empotrar
administrator
Suscriptores
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the treatment of renal cell carcinoma and the current role for immunotherapy agents.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios